+33 1 76 70 47 90 / creativ@creativ-ceutical.com

[PMU17] Additional benefit scoring during health technology assessment in Germany its drivers and impact on pricing and discount for orphan drugs

[PMU17] Additional benefit scoring during health technology assessment in Germany its drivers and impact on pricing and discount for orphan drugs

2018 ISPOR Asia

Fukushima, A. | Dorey, J. | Toumi, M. | Volume: , Issue: , Pages: ,